The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including anaphylaxis. The agency said it approved Neffy, from ARS Pharmaceuticals, for use in adult and pediatric patients who weigh at least 30 kilograms (about 66 pounds). In a surprise move last year, FDA declined to approve Neffy despite a favorable recommendation from an advisory committee. Instead, the agency asked the manufacturer to complete a study comparing repeat doses of Neffy to repeat doses of epinephrine injection. “Anaphylaxis is life-threatening and some people, particular
Hence then, the article about fda approves epinephrine nasal spray a needle free alternative to epipen was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA approves epinephrine nasal spray, a needle-free alternative to EpiPen )